Literature DB >> 18624682

An updated review of acitretin--a systemic retinoid for the treatment of psoriasis.

Mei-Lin Pang1, Jenny E Murase, John Koo.   

Abstract

BACKGROUND: Acitretin is a systemic retinoid used for psoriasis. It normalizes cellular differentiation and maturation and is also used as a chemopreventive agent against cutaneous malignancies. However, it is not used frequently because of its side-effect profile.
OBJECTIVE: Safety and efficacy of acitretin was evaluated as monotherapy, as well as in combination with other systemic agents.
METHODS: Medical literature from 2005 to 2008 was reviewed. The most scientifically rigorous clinical trials were selected for Psoriasis Area and Severity Index. Articles were limited to case reports or clinical trials, human subjects and English language journals. RESULTS/
CONCLUSION: Acitretin is effective as monotherapy for pustular and erythrodermic psoriasis and for plaque psoriasis (with other systemic agents). Side effects of acitretin use occur more commonly with high doses. Hence, acitretin is safe and effective for psoriasis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18624682     DOI: 10.1517/17425255.4.7.953

Source DB:  PubMed          Journal:  Expert Opin Drug Metab Toxicol        ISSN: 1742-5255            Impact factor:   4.481


  11 in total

1.  Outcomes of Acitretin Treatment for Refractory Multikinase Inhibitor-Induced Hand-Foot Skin Reaction.

Authors:  Jordan T Said; Sean Singer; Lisa Iannattone; Maxwell Sauder; Nicole R LeBoeuf
Journal:  JAMA Dermatol       Date:  2022-07-01       Impact factor: 11.816

2.  Doppler versus Histopathology in the Assessment of Egyptian Patients with Psoriasis Treated with Acitretin.

Authors:  Mohamed H Khater; Mohamed Soliman; Amin Amer; Fatehy Khater; Manal R Abd Elhaleem
Journal:  J Clin Aesthet Dermatol       Date:  2017-11-01

Review 3.  Hand dermatitis: an allergist's nightmare.

Authors:  Lindsey Wold; Jennifer K Chen; Heather P Lampel
Journal:  Curr Allergy Asthma Rep       Date:  2014-11       Impact factor: 4.806

4.  Acitretin and Retinoic Acid Derivatives Inhibit BK Polyomavirus Replication in Primary Human Proximal Renal Tubular Epithelial and Urothelial Cells.

Authors:  Zongsong Wu; Fabrice E Graf; Hans H Hirsch
Journal:  J Virol       Date:  2021-07-12       Impact factor: 5.103

5.  RNA sequencing-based longitudinal transcriptomic profiling gives novel insights into the disease mechanism of generalized pustular psoriasis.

Authors:  Lingyan Wang; Xiaoling Yu; Chao Wu; Teng Zhu; Wenming Wang; Xiaofeng Zheng; Hongzhong Jin
Journal:  BMC Med Genomics       Date:  2018-06-05       Impact factor: 3.063

6.  A Delphi Consensus Approach to Challenging Case Scenarios in Moderate-to-Severe Psoriasis: Part 2.

Authors:  Bruce E Strober; Jennifer Clay Cather; David Cohen; Jeffrey J Crowley; Kenneth B Gordon; Alice B Gottlieb; Arthur F Kavanaugh; Neil J Korman; Gerald G Krueger; Craig L Leonardi; Sergio Schwartzman; Jeffrey M Sobell; Gary E Solomon; Melodie Young
Journal:  Dermatol Ther (Heidelb)       Date:  2012-03-30

Review 7.  Treating pediatric plaque psoriasis: challenges and solutions.

Authors:  Jayakar Thomas; Kumar Parimalam
Journal:  Pediatric Health Med Ther       Date:  2016-04-21

8.  Erythrodermic psoriasis: pathophysiology and current treatment perspectives.

Authors:  Rasnik K Singh; Kristina M Lee; Derya Ucmak; Merrick Brodsky; Zaza Atanelov; Benjamin Farahnik; Michael Abrouk; Mio Nakamura; Tian Hao Zhu; Wilson Liao
Journal:  Psoriasis (Auckl)       Date:  2016-07-20

9.  Efficacy of acitretin in the treatment of reactive neutrophilic dermatoses in adult-onset immunodeficiency due to interferon-gamma autoantibody.

Authors:  Rujira Rujiwetpongstorn; Mati Chuamanochan; Napatra Tovanabutra; Romanee Chaiwarith; Siri Chiewchanvit
Journal:  J Dermatol       Date:  2020-03-23       Impact factor: 4.005

Review 10.  Targeting ADAM10 in Cancer and Autoimmunity.

Authors:  Timothy M Smith; Anuj Tharakan; Rebecca K Martin
Journal:  Front Immunol       Date:  2020-03-24       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.